Abstract
Sustained blood cell production requires preservation of a quiescent, multipotential stem cell pool that intermittently gives rise to progenitors with robust proliferative potential. The ability of cells to shift from a highly constrained to a vigorously active proliferative state is critical for maintaining stem cells while providing the responsiveness necessary for host defense. The cyclin-dependent kinase inhibitor (CDKI), p21cip1/waf1 (p21) dominates stem cell kinetics. Here we report that another CDKI, p27kip1 (p27), does not affect stem cell number, cell cycling, or self-renewal, but markedly alters progenitor proliferation and pool size. Therefore, distinct CDKIs govern the highly divergent stem and progenitor cell populations. When competitively transplanted, p27-deficient stem cells generate progenitors that eventually dominate blood cell production. Modulating p27 expression in a small number of stem cells may translate into effects on the majority of mature cells, thereby providing a strategy for potentiating the impact of transduced cells in stem cell gene therapy.
Similar content being viewed by others
Main
Blood cell turnover in humans requires the production of tens of billions of cells per day with rapid increments during times of physiological stress. Maintenance of cell production requires a highly cytokine-responsive progenitor cell pool with prodigious proliferative capacity and a smaller population of stem cells intermittently feeding daughter cells into the proliferative compartment. The stem cell pool itself is relatively quiescent and cytokine resistant, a state that seems to be necessary for the prevention of premature depletion during times of stress1,2,3. The dichotomy of resistance to proliferative signals by stem cells as compared with the brisk responsiveness by progenitor cells is a central feature of the blood-forming compartment that is poorly understood.
It has recently been demonstrated that entry into the cell cycle in stem cells is governed by the CDKI, p21. In the absence of this inhibitor, the stem cell pool is larger, more actively cycling, and more sensitive to exhaustion. Dominant inhibitory control over stem cell cycling exerted by p21 dictates the size and kinetics of the stem cell compartment, and preserving the stem cell population is dependent on restricting access into the cell cycle4.
Hypothesizing that distinct molecular mechanisms may predominate in the stem cell compartment as compared to its prolific descendent progenitor pool, we evaluated other CDKI family members. The Cip/Kip family of CDKIs includes p21, p27, and p57kip2. The p27 molecule differs from p21 in its C terminus; it interacts with similar but not identical cyclin-CDKs, and it lacks p53-regulated expression5,6,7. The p27−/− mouse is also markedly different from the p21−/− mouse, with a larger body habitus, hyperplasia of most organs (including hematopoietic organs), spontaneous generation of benign pituitary tumors, and infertility8,9,10. Like p21, however, p27 is associated with postmitotic differentiation in some cell types11,12,13, and antisense p27 can suppress cell cycle arrest in mesenchymal cells14,15. Unlike p21, p27 is controlled by both translational and post-translational mechanisms16,17, and p27 has been uniquely demonstrated to be an intrinsic timer for proliferation of neural cells, restricting the number of cell divisions18,19. A role for p27 in hematopoiesis is supported directly by flow cytometric evidence for expression in primitive cells 20 and expression in more mature progenitors 21,22, and indirectly by improved retroviral transduction in the context of antisense p27 (ref. 23). We investigated the function of p27 in the hematopoietic cascade through the use of mice engineered to be deficient in p27 and a series of in vitro and in vivo measures of stem and progenitor cell function.
Stem or progenitor cell pool size
We first assessed the impact of p27 deletion on different hematopoietic cell compartments by quantifying the functional populations of progenitor cells (using methylcellulose colony-forming cell (CFC) assays) and of more primitive cells (using long-term cobblestone area-forming cell (CAFC) assays24,25. The latter assays correlate linearly with in vivo repopulating potential and were used here as a functional stem cell assay.
We observed a marked contrast between p27−/− mice and p21−/− mice. In the p21−/− animals, stem cell populations were doubled and progenitor populations unchanged in previous studies4,26, whereas p27−/− animals had an increase in progenitors but no change in stem cell numbers. Decreased numbers of CAFCs per nucleated cell in the p27−/− animals were noted compared to +/+ animals (33% reduction of CAFC frequency in −/− animals, n = 7, P = 0.0391). However, normalization of the values for the overall increase in marrow cellularity in the p27−/− mouse (4.40 vs. 2.83 × 107/femur pair; P = 0.0072; n = 6) indicated that the number of stem cells per hematopoietic organ was not significantly different from the +/+ control (P = 0.3861, n = 7) (Fig. 1a). However, the progenitor population was significantly different, with an increased CFC population in p27−/− versus +/+ animals (P = 0.0006, n = 5) (Fig. 1b). Therefore, a disproportionate increase in progenitor populations and overall cellularity diluted the stem cell fraction, but the absolute number of stem cells was unchanged from control.
Cell cycle profile
To directly measure cell cycle parameters of primitive cell populations in the p27+/+ and −/− animals, we carried out flow cytometric analysis. Because hematopoietic stem cells have been shown to be positive for the stem cell marker Sca-1 and negative for lineage markers 27, we reasoned that lineage marker-expressing cells in the Sca-1+ population reflected a population of maturing lineage-committed progenitors. We confirmed this by testing for CAFC and detected a decrease of 9–20 times in Lin+Sca-1+ cells compared to Lin−Sca-1+ cells. Therefore, we used flow cytometry to separate the enriched stem cell (Sca-1+Lin−) and progenitor cell (Sca-1+Lin+) pools from marrow nucleated cells, and analyzed the cell cycle status (S+G2/M percentage) by simultaneously staining with the DNA dye, To-pro-3. We observed a similar S+G2/M percentage of Sca-1+Lin− in the p27+/+ and −/− animals (P = 0.3591, n = 6), but a higher S+G2/M percentage of Sca-1+Lin+ in the p27−/− animals (Fig. 2a and 2b, P = 0.0215, n = 7). To further distinguish a quiescent fraction (G0) versus G1 in the stem cell pool, we used the RNA dye, Pyronin Y, to stain the marrow nucleated cells within a stringent gate of Lin− cells in conjunction with a DNA dye, Hoechst 333421,28. No significant difference was observable between p27−/− and +/+ cells (Fig. 2c), unlike the p21−/− stem cells, in which a significantly lower fraction of quiescent cells had been previously found4. These data indicate an unperturbed cell cycle status of stem cells, but an increased fraction of progenitor cells in active cycle in the absence of p27.
For functional evaluation of cell cycle status we exposed animals to the cell cycle-dependent antimetabolite 5-fluorouracil (5-FU), which selectively kills cycling cells29,30. Littermate −/− or +/+ mice received injections of 200 mg/kg of 5-FU or phosphate-buffered saline alone; marrow was harvested one day later, and CAFC and CFC assays performed (Fig. 3). No difference in the yield of CAFC was noted between +/+ and −/− animals, indicating similar proliferative kinetics in the primitive or stem cell compartment (P = 0.2852, n = 6). However, we observed a significant reduction of CFC after 5-FU injection in the p27−/− group compared to the +/+ group controls (82.7% versus 50.6%, P = 0.0044, n = 5) (Fig. 3). The proliferative fraction of cells in the progenitor pool was therefore larger in those animals lacking p27, providing a basis for the expanded size of the progenitor cell population.
Apoptotic fraction
Under homeostatic conditions, an enlarged cell population in vivo may be caused by increased cell proliferation, decreased cell death, or both. To assess whether or not altered apoptosis contributed to the expanded progenitor compartment, we evaluated cells by Annexin-V staining31 and could detect no difference in apoptosis in either the Sca-1+Lin− stem cell pool or Sca-1+Lin+ progenitor cells between p27−/− and +/+ littermate control mice (mean 2.5 ± 0.8 vs. 2.5 ± 0.8 and 7.3 ± 2.5 vs. 7.2 ± 2.2, respectively; n = 4).
Transplantation analysis of stem and progenitor cells
Reasoning that steady state of the stem cell compartment may be unperturbed yet other physiological functions affected under stress, we carried out sequential bone marrow transplantation. Bone marrow from p27+/+ or −/− male animals in each genotype was transplanted into 10 lethally irradiated female mice. One to four months after engraftment, 1–2 × 106 bone marrow cells from the transplanted recipients were used as donor cells for a lethally irradiated host and the same procedure was repeated sequentially. Chimerism was determined as ∼100% donor derived after each transplant by semiquantitative Y chromosome-specific (Sry) polymerase chain reaction (PCR)32 and p27 genotyping PCR (data not shown). There was no difference in bone marrow homing among p27−/− stem cells compared to +/+ controls as assessed by carboxyfluorescein diacetate succinimidyl diester33,34 staining of Sca-1+Lin− cells (data not shown). Stem cell quantitation was performed by CAFC analysis after each transplantation. A comparable decay rate in CAFC was noted in each group, indicating that stem cell renewal was equivalent in the p27−/− and +/+ animals (Fig. 4a).
Interestingly, however, the progenitor cell pool from the p27−/− animals was capable of expansion and relative regeneration after serial transplantation when wild-type progenitors were markedly depleted (Fig. 4b). Furthermore, the functional capacity of these cells was evident in improved animal survival in a short-term radiation-protection assay (Fig. 4c), even after the fourth serial transplant when stem cells were no longer detectable. These data demonstrate markedly altered cell kinetics among progenitors, but not stem cells, in the absence of p27. This contrasts dramatically with the increased stem cell pool and unaffected progenitor population in the p21−/− setting4.
Competitive repopution
We next tested the role of p27 and thereby the role of progenitor cell cycle inhibition in the context of long-term engraftment. We performed a competitive transplantation in which −/− and +/+ bone marrow nucleated cells were admixed 1:1 and transplanted into an irradiated wild-type recipient. It should again be noted that the representation of stem cells in the −/− nucleated cell preparations is proportionately lower than in +/+ controls. The admixture of the stem cell population is therefore uneven, with 40% derived from −/− marrow. After transplantation, semiquantitative PCR of p27 was used to monitor each genotype in populations of bone marrow and blood cells over a one-year interval. It has been shown in other settings that the proportion of stem cells from a normal host is reflected in a similar proportion of total bone marrow cells and blood cells35,36. This is the basis for the competitive repopulation experiments performed in congenic mice as a tool for measuring stem cell populations. However, in the context of altered cell cycle regulation by p27 deficiency, proportionate representation in various cellular compartments was strikingly altered.
Even though the fraction of −/− stem cells transplanted was approximately 40%, after six months the fraction of p27−/− cells in the blood reached levels of ∼80% and was sustained at elevated levels (Fig. 5a). In addition, the fraction of −/− marrow nucleated cells (predominantly a progenitor cell population and its descendents) was also >80% at the time of euthanasia at 11 or 12 months (Fig. 5b). We carried out long-term culture initiating cell (LTC-IC), and CFC analyses on the marrow specimens. Individual CAFC, LTC-IC or CFC were then isolated by micropipette for PCR analysis of the p27 genotype. The data confirmed that the proportion of genotypically −/− cells in the CAFC, LTC-IC, or stem cell population was comparable to or less than what was transplanted. In contrast, the CFC or progenitor cell population demonstrated a relative overrepresentation of the −/− genotype (Fig. 5c). The fraction of stem cells transplanted thereby contributed disproportionately to the progenitor cell population, which in turn contributed disproportionately to the blood cell population in the absence of p27. Feedback governing cell pool size therefore is skewed in the absence of p27, permitting overgrowth of progenitors and their descendents in a competitive situation (Fig. 5d).
Discussion
These data support highly differentiation stage–specific regulatory roles for distinct members of the CDKI Cip/Kip family (Table 1). The clearly delineated and apparently exclusive dominance of p27 in progenitor cells and of p21 in stem cells demarcates a molecular boundary that is unique as far as we know. Cytokine receptors30, chemokine receptors37, adhesion molecules38,39, and transcription factors40,41,42,43 have been shown to be expressed in overlapping populations of precursor populations. Whereas other regulatory molecules may contribute to the differential sensitivity of stem cells and progenitors to proliferative signals, cell cycle control is highly divergent at the level of the G1-S checkpoint. The distinction between the participating CDKIs may explain in part the highly dichotomous proliferative capability of stem cells as compared to the progenitor cells that characterize the hematopoietic and other differentiation systems. Additionally, it provides specific targets for selective manipulation of stem cell versus progenitor cell compartments. To the extent that hematopoiesis mimics other stem and progenitor populations in tissue development, this distinction may point to useful strategies for altering specific precursor pools in size and activity.
The observation that competition between p27−/− and +/+ cells results in overrepresentation of the −/− progenitor and blood cells indicates the critical function of inhibition in dictating homeostasis in the later phases of hematopoiesis. The importance of pro-proliferative cues for hematopoiesis has been demonstrated44, but the crucial involvement of inhibitors of proliferation is demonstrated in the p27−/− mice in this study for progenitors and in p21−/− mice for stem cells elsewhere4. Where there is an inability to exert the cell cycle inhibition mediated by these molecules, disruption of normal population kinetics occurs. However, the proliferation that does occur in the p21−/− and p27 −/− mice is not as overwhelming as has been observed, for example, with disruption by an inhibitory cytokine such as TGF-β (ref. 45). Although the p27−/− animals have slightly higher blood counts than +/+ controls (white blood cells, 9.08 ± 3.12 vs. 6.89 ± 2.11 × 103/μl; erythrocytes, 8.37 ± 1.09 vs. 8.26 ± 1.41 × 106/μl; platelets, 723.10 + 172.74 vs. 635.40 ± 105.40 × 103/μl; n = 10), neither the p27- nor p21-deficient animals develop leukemia or gross polycythemia as indicated by cell counts, morphology, and phenotypic analysis by flow cytometry (data not shown). Therefore, other negative regulators must be active beyond a certain threshold of cell expansion. It is within physiological ranges of the hematopoietic compartment size that p27 and p21 appear to exert dominant roles in modulating cell dynamics.
The ability of a minority population of p27−/− stem cells to predominate in the progenitor and mature blood cell compartments indicates the potential efficacy of using p27 to enhance the efficiency of small numbers of stem cells. A controlled reduction in p27 might make it possible to effect a marked alteration in a substantially larger fraction of blood cells, particularly in the settings where small numbers of stem cells may be transduced with a therapeutic gene. The absence of an untoward effect in vivo demonstrated in the p27−/− mouse provides conceptual support, although extensive additional experimental evidence is needed. The ability of this genetic alteration to increase the size of other, nonhematopoietic tissues in vivo8,9,10 indicates that controlled manipulation of p27 may also be relevant for the expansion or possible regeneration of other tissue types.
Methods
Generation of homozygous mice.
We obtained heterozygote 129/B6 p27 +/− mice from the laboratory of Dr. Andrew Koff (Sloan-Kettering Cancer Center, New York) under the permission of the Subcommittee on Research Animal Care of the Massachusetts General Hospital (MGH). Mice were housed in sterilized microisolator cages and received autoclaved food and drinking water at the MGH animal core facility. The heterozygotes (+/−) were backcrossed into 129/sv background and bred to yield homozygous and wild-type offspring. The littermates from the same +/−parents were used in each experiment.
Mouse genotyping.
Genotyping was accomplished by DNA PCR. Briefly, genomic DNA was isolated from tail biopsy and analyzed by amplification using three primers (the sequences were provided by Dr. Andrew Koff): SW40 (5′-TCA AAC GTG AGA GTG TCT AAC GG -3′), SW41 (5′- AGG GGC TTA TGA TTC TGA AAG TCG -3′), and SW39 (5′-ATA TTG CTG AAG AGC TTG GCG G -3′). SW40 is a forward primer that binds the region nucleotides 4–26 of pLamda-KIP-34-1. Used in conjunction with SW41, a reverse primer binding to nucleotides 209–186 of pLamda-KIP-34-1, this will produce a PCR product of 206 bp from the wild-type locus. SW40 used in conjunction with SW39, a forward primer binding to nucleotides 1420–1441 of PMC1POLA, will produce a PCR product of 298 bp from the mutant locus. All three primers were used together in the same reaction to detect wild-type and mutant loci. The conditions for thermocycling were as follows: (step 1) 94 °C, 4 min; (step 2) 35 cycles of 90 °C, 30 s, 55 °C, 30 s, 72 °C, 1 min; (step 3) 72 °C, 10 min. Diagnostic mutant and wild-type amplified bands were detected on a 2.0% agarose gel post-visualization with ethidium bromide. Semiquantitative PCR was done using 1 μg of genomic DNA. The same primers and thermocycling parameters were applied as above, except that only 28 cycles were carried out for step 2. The ratios of these PCR products were compared against a proportional titration curve of mutant and wild-type amplified bands (Fig. 5a).
Bone marrow sampling.
Mouse bone marrow was obtained from eight to twelve week-old animals from each group (−/−, +/+) after euthanizing with CO2. The marrow cell suspensions were flushed from femurs and tibias, filtered with 100-mesh nylon cloth (Sefar America, Inc., Kansas City, Missouri), and stored on ice until use.
Flow cytometric analysis.
Flow cytometry was used to quantify the cell cycle status in the stem cell compartment. Bone marrow nucleated cells were labeled with anti-lineage antibodies (CD3, CD4, CD8, B220, Gr-1 and Mac-1 from Caltac (Burlingame, California); TER-119 from PharMingen (San Diego, California)) and stem cell marker (Sca-1; PharMingen, San Diego, California). An enriched stem cell phenotype (Sca-1+Lin−) and a progenitor phenotype (Sca-1+Lin+) were gated, and a DNA dye, To-pro-3, was used to stain the antibody-bound cells simultaneously to measure the cycling cell percentage in the populations. To measure stem cell quiescence, cells were stained with lineage antibodies, incubated with 1.67 μmol/L DNA dye, Hoechst 33342, and 1 μg/ml RNA dye, Pyronin Y, and the ratio of G0 vs. G1 was then measured in the Lin− population28. To detect apoptotic cells, Annexin-V (Caltac, Burlingame, California) in conjunction with the DNA dye 7-AAD (refs. 31,37), was used to stain Sca-1+, Lin−, or Lin+ cells, which were then analyzed by flow cytometry. Cells excluding 7-AAD and binding Annexin-V were considered apoptotic.
Colony-forming assay.
This assay was used to measure the progenitor cell frequency (CFC) as described in our previous publication4. Murine stem cell factor (SCF) was used in this study instead of human SCF in the previous one.
Long-term culture with limiting dilution.
To quantify the stem cells, we adapted the CAFC assay 25 with minor modifications as described in our previous publication4.
Serial bone marrow transplantation.
Serial bone marrow transplantation was used to evaluate the ability of stem cells to self-renew as described in our previous publication4. Briefly, male mice were used as marrow donors. Female recipient mice were lethally irradiated with 10 Gy whole-body irradiation at 5.96 Gy/min. Two million nucleated cells were injected intravenously into the lateral tail veins of warmed recipients. Recipient mice were monitored daily for survival for more than one month. The mice were euthanized after one to four months, and bone marrow cells were prepared from those euthanized and injected into new female irradiated recipients. This process was repeated four more times
Short-term radiation-protection assay.
105 marrow nucleated cells from the fourth transplant were transplanted into lethally irradiated female mice as described above, and animal survival frequency was plotted for each group after 30 days. Results were analyzed using a log-rank nonparametric test and expressed as Kaplan–Meier survival curves.
Competitive long-term repopulation.
Equal numbers of bone marrow nucleated cells from p27+/+ and p27−/− mice were mixed and transplanted into the lethally irradiated recipients as described in the serial transplantation section. Blood was collected at six and nine months for semiquantitative p27 PCR analysis. After 12 months, mice were euthanized and bone marrow nucleated cells were prepared for PCR analysis and hematopoietic cell culture (CFC, CAFC, and LTC-IC; see the CFC and long-term culture sections). Individual colonies from the CFC culture or individual CAFC/LTC-ICs from different wells were isolated by micropipette and analyzed by PCR for p27.
References
Mauch, P., Ferrara, J. & Hellman, S. Stem cell self-renewal considerations in bone marrow transplantation. Bone Marrow Transplant. 4, 601–607 (1989).
Mauch, P. et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 31, 1319–1339 (1995).
Gardner, R.V., Astle, C.M. & Harrison, D.E. Hematopoietic precursor cell exhaustion is a cause of proliferative defect in primitive hematopoietic stem cells (PHSC) after chemotherapy. Exp. Hematol. 25, 495–501 (1997).
Cheng, T. et al. Hematopoietic stem cell quiescence maintained by p21(cip1/waf1). Science 287, 1804–1808 (2000).
Polyak, K. et al. p27kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9–22 (1994).
Sherr, C.J. & Roberts, J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149–1163 (1995).
Sherr, C.J. Cancer cell cycles. Science 274, 1672–1677 (1996).
Kiyokawa, H. et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85, 721–732 (1996).
Fero, M.L. et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85, 733–744 (1996).
Nakayama, K. et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707–720 (1996).
Asiedu, C., Biggs, J. & Kraft, A.S. Complex regulation of CDK2 during phorbol ester-induced hematopoietic differentiation. Blood 90, 3430–3437 (1997).
Liu, M., Iavarone, A. & Freedman, L.P. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J. Biol. Chem. 271, 31723–31728 (1996).
Kranenburg, O., Scharnhorst, V., Van der Eb, A.J. & Zantema, A. Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J. Cell. Biol. 131, 227–234 (1995).
Coats, S., Flanagan, W.M., Nourse, J. & Roberts, J.M. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272, 877–880 (1996).
Rivard, N., L'Allemain, G., Bartek, J. & Pouyssegur, J. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J. Biol. Chem. 271, 18337–18341 (1996).
Hengst, L. & Reed, S.I. Translational control of p27Kip1 accumulation during the cell cycle. Science 271, 1861–1864 (1996).
Pagano, M. et al. Role of the ubiquitin–proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 [see comments]. Science 269, 682–685 (1995).
Levine, E.M., Close, J., Fero, M., Ostrovsky, A. & Reh, T.A. p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina. Dev. Biol. 219, 299–314 (2000).
Durand, B., Fero, M.L., Roberts, J.M. & Raff, M.C. p27kip1 alters the response of cells to mitogen and is part of a cell- intrinsic timer that arrests the cell cycle and initiates differentiation. Curr. Biol. 8, 431–440 (1998).
Tong, X. & Srour, E.F. TGF-β suppresses cell division of Go CD34+ cells while maintaining primitive hematopoietic potential. Exp. Hematol. 26, 684 (1998).
Taniguchi, T. et al. Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis. Blood 93, 4167–4178 (1999).
Yaroslavskiy, B., Watkins, S., Donnenberg, A.D., Patton, T.J. & Steinman, R.A. Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells. Blood 93, 2907–2917 (1999).
Dao, M.A., Taylor, N. & Nolta, J.A. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cell. Proc. Natl. Acad. Sci. USA 95, 13006–13011 (1998).
Ploemacher, R.E., van der Sluijs, J.P., Voerman, J.S. & Brons, N.H. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 74, 2755–2763 (1989).
Ploemacher, R.E., van der Sluijs, J.P., van Beurden, C.A., Baert, M.R. & Chan, P.L. Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. Blood 78, 2527–2533 (1991).
Mantel, C. et al. Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo. Blood 88, 3710–3719 (1996).
Spangrude, G.J., Heimfeld, S. & Weissman, I.L. Purification and characterization of mouse hematopoietic stem cells Science 241, 58–62 (1988). (Published erratum appears in Science 244, 1030, 1989.)
Gothot, A., Pyatt, R., McMahel, J., Rice, S. & Srour, E.F. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle. Blood 90, 4384–4393 (1997).
Lerner, C. & Harrison, D.E. 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp. Hematol. 18, 114–118 (1990).
Berardi, A.C., Wang, A., Levine, J.D., Lopez, P. & Scadden, D.T. Functional isolation and characterization of human hematopoietic stem cells. Science 267, 104–108 (1995).
Fadok, V.A. et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148, 2207–2216 (1992).
Muller, A.M. & Dzierzak, E.A. ES cells have only a limited lymphopoietic potential after adoptive transfer into mouse recipients. Development 118, 1343–1351 (1993).
Weston, S.A. & Parish, C.R. New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J. Immunol. Methods 133, 87–97 (1990).
Grzegorzewski, K. et al. Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin. J. Exp. Med. 180, 1047–1057 (1994).
Harrison, D.E. Competitive repopulation: a new assay for long-term stem cell functional capacity. Blood 55, 77–81 (1980).
Szilvassy, S.J., Humphries, R.K., Lansdorp, P.M., Eaves, A.C. & Eaves, C.J. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc. Natl. Acad. Sci. USA 87, 8736–8740 (1990).
Shen, H. et al. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J. Virol. 73, 728–737 (1999).
Becker, P.S. et al. Adhesion receptor expression by hematopoietic cell lines and murine progenitors: modulation by cytokines and cell cycle status. Exp. Hematol. 27, 533–541 (1999).
Roy, V. & Verfaillie, C.M. Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis. Exp. Hematol. 27, 302–312 (1999).
Cheng, T. et al. Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. Proc. Natl. Acad. Sci. USA 93, 13158–13163 (1996).
Shivdasani, R.A. & Orkin, S.H. The transcriptional control of hematopoiesis [see comments]. Blood 87, 4025–4039 (1996).
Tenen, D.G., Hromas, R., Licht, J.D. & Zhang, D.E. Transcription factors, normal myeloid development, and leukemia. Blood 90, 489–519 (1997).
Testa, U. et al. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood 88, 3391–3406 (1996).
Carver-Moore, K. et al. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Blood 88, 803–808 (1996).
Shull, M.M. et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693–699 (1992).
Acknowledgements
This work was supported by NIH grants HL 44851, DK 50234, and HL 55718 (D.T.S.), AI07387 and DK02761 (T.C.), the Richard Saltonstall Charitable Foundation (D.T.S.) and the Deutscher Akademischer Austuaschdienst (S.S). The authors thank Andrew Koff (Sloan-Kettering Cancer Center, New York) for p27+/− mice, Youngguang Yang, Nadia Carlesso, and Frederic Preffer for technical assistance and helpful discussions.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Cheng, T., Rodrigues, N., Dombkowski, D. et al. Stem cell repopulation efficiency but not pool size is governed by p27kip1. Nat Med 6, 1235–1240 (2000). https://doi.org/10.1038/81335
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/81335
This article is cited by
-
Cell-intrinsic factors governing quiescence vis-à-vis activation of adult hematopoietic stem cells
Molecular and Cellular Biochemistry (2023)
-
High ploidy large cytoplasmic megakaryocytes are hematopoietic stem cells regulators and essential for platelet production
Nature Communications (2023)
-
Slc20a1b is essential for hematopoietic stem/progenitor cell expansion in zebrafish
Science China Life Sciences (2021)
-
Hypercholesterolemia Accelerates the Aging Phenotypes of Hematopoietic Stem Cells by a Tet1-Dependent Pathway
Scientific Reports (2020)
-
In vivo selection with lentiviral expression of Bcl2T69A/S70A/S87A mutant in hematopoietic stem cell-transplanted mice
Gene Therapy (2018)